By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Domain Therapeutics 

Strasbourg      France
Phone: n/a Fax: n/a


Company News
Domain Therapeutics Launches Specific Purpose Vehicle Kaldi Pharma To Harness The Potential Of Its Adenosine Programs 3/4/2015 9:24:38 AM
Domain Therapeutics Appoints Professor Michel Bouvier As Chairman Of The Scientific Advisory Board 9/22/2014 9:25:02 AM
Domain Therapeutics Appoints Dr Youssef L. Bennani As Chairman Of The Board 5/27/2014 11:30:17 AM
Domain Therapeutics Continues Program To Alter Course Of Parkinson's Disease With Renewed Support By The Michael J. Fox Foundation 4/14/2014 8:34:04 AM
Domain Therapeutics Enters Into Collaboration With XOMA Corporation (XOMA) 2/4/2014 9:28:32 AM
Domain Therapeutics Opens A North American Subsidiary At Montreal's NEOMED Institute 1/20/2014 9:02:19 AM
Domain Therapeutics, Université de Montréal And McGill University Sign New Licensing And Partnership Agreement On G-Protein Coupled Receptor Biosensor Technology 12/18/2013 9:26:38 AM
Domain Therapeutics Grants Prexton Therapeutics an Exclusive Option to License and Develop mGluR4 PAMs for Parkinson's Disease 1/22/2013 11:20:58 AM
Domain Therapeutics Enters Into Collaboration Agreement With Ono Pharmaceutical Company, Ltd. in the Field of GPCR-Based Drug Discovery 10/23/2012 9:47:01 AM
Domain Therapeutics Closes EUR Two Million Funding Round 7/17/2012 12:08:56 PM